18 Mar Neurovascular Devices Market 2025-2033: Global Industry Overview, Sales Revenue, Demand and Opportunity
Neurovascular Devices Market Overview
The global neurovascular devices market, valued at USD 3.0 billion in 2024, is projected to reach USD 4.7 billion by 2033, exhibiting a CAGR of 4.9% from 2025 to 2033. This growth is driven by the increasing prevalence of neurovascular disorders such as strokes and aneurysms, advancements in minimally invasive technologies, and a growing geriatric population. North America leads the market, holding a 27.8% share in 2024, attributed to advanced healthcare infrastructure and strong research support.
Study Assumption Years
- Base Year: 2024
- Historical Years: 2019-2024
- Forecast Years: 2025-2033
Neurovascular Devices Market Key Takeaways
- Market Size and Growth: The market is expected to grow from USD 3.0 billion in 2024 to USD 4.7 billion by 2033, at a CAGR of 4.9%.
- Regional Performance: North America dominates with a 27.8% market share in 2024, driven by advanced healthcare infrastructure and high adoption of innovative devices.
- Product Segmentation: Key products include cerebral embolization and aneurysm coiling devices, cerebral angioplasty and stenting systems, neurothrombectomy devices, and support devices.
- Application Areas: Devices are primarily used for ischemic stroke, aneurysm, arteriovenous malformation and fistulas (AVM), stenosis, and other neurovascular conditions.
- End Users: Hospitals, ambulatory surgical centers, clinics, and other healthcare facilities are the primary users of neurovascular devices.
Market Growth Factors
The neurovascular devices market is experiencing significant growth due to several key factors:
Technological Advances: Continuous innovations on the neurovascular devices flow diverters, thrombectomy devices, and embolization coils have improved procedural outcomes. These minimally invasive technologies decrease risk, shorten recovery time, and provide individualized solutions so that they can be rapidly adopted into healthcare institutions worldwide.
Regulatory Impact: Better reimbursement policies being adopted in a number of countries have made neurovascular treatments widely accessible and affordable. In turn, conducive regulatory environments accelerate the uptake of advanced devices so that neurovascular condition patients receive effective and timely intervention.
Increasing Market Demand: The rising incidence of neurovascular disorders, coupled with an aging population that is susceptible to these conditions, has further compounded the demand for effective solutions. These advanced neurovascular devices are increasingly being demanded due to rising awareness and early diagnosis, which also plays a role in increasing market growth.
Request Sample For PDF Report: https://www.imarcgroup.com/neurovascular-devices-market/requestsample
Market Segmentation:
Analysis by Product:
- Cerebral Embolization and Aneurysm Coiling Devices
- Embolic Coils
- Flow Diverters
- Liquid Embolic Agents
- Cerebral Angioplasty and Stenting Systems
- Carotid Artery Stents
- Embolic Protection Devices
- Neurothrombectomy Devices
- Clot Retrieval Devices
- Suction Devices
- Vascular Snares
- Support Devices
- Micro Catheters
- Micro Guidewires
Analysis by Application:
- Ischemic Stroke
- Aneurysm
- Arteriovenous Malformation and Fistulas (AVM)
- Stenosis
- Others.
Analysis by End User:
- Hospitals
- Ambulatory Surgical Centers
- Clinics
- Others
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Regional Insights
North America leads the neurovascular devices market, holding a 27.8% share in 2024. This dominance is attributed to advanced healthcare infrastructure, widespread adoption of innovative neurovascular devices, increasing cases of neurovascular disorders, and strong support for research initiatives.
Recent Developments & News
In January 2025, Stryker, a prominent medical device company, announced its acquisition of Inari Medical for $4.9 billion. This strategic move aims to enhance Stryker’s portfolio in treating peripheral vascular diseases by integrating Inari’s expertise in venous thromboembolism treatments. The deal reflects the growing demand for advanced medical implant devices, especially as deferred surgeries from the COVID-19 pandemic resume.
Key Players:
- Acandis GmbH
- Asahi Intecc Co. Ltd.
- Imperative Care Inc.
- Integer Holdings Corporation
- Johnson & Johnson
- Medtronic plc
- MicroPort Scientific Corporation
- Penumbra Inc.
- Perflow Medical Ltd.
- Rapid Medical
- Stryker Corporation
- Terumo Corporation
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Sin comentarios